Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Core One Labs Inc > Nice move into the 70's after accumulating nicely mid 60's
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(928)
•••
Comment by CancerSlayeron Dec 23, 2020 10:30am
108 Views
Post# 32168807

RE:RE:Nice move into the 70's after accumulating nicely mid 60's

RE:RE:Nice move into the 70's after accumulating nicely mid 60's

SCORPION34 wrote: Totally new management and new business. Already have medical clinics for treatments. Vocan deal is first class with the individuals invloved. Dr Robert Hancock has some serious credentials. Just wait until they start to put out somes news. 

 

Medical clinics in place for treatments & future clinical trials is a great start.  Any updates on Dr. Sanderson's patent regarding the sublingual strip technology?  Hopefully this pending technology (whether it be for sublingual cannabis or psilocybin) becomes an IP reality.  Many have been waiting a looooong time for patent protection & even a semblance of a clinical trial.  The value such IP would "finally" bring to this company would be immeasurable, not to mention help remove old doubt & incite more serious investor interest imo.  Hopefully, this new ringleader can turn the old circus act into a legit performance.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities